Simsir IY - Search Results

1

Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?

Cetinkalp S, Simsir IY, Sahin F, Saydam G, Ural AU, Yilmaz C. Cetinkalp S, et al. Among authors: simsir iy. Saudi Pharm J. 2015 Jan;23(1):14-21. doi: 10.1016/j.jsps.2013.12.009. Epub 2013 Dec 22. Saudi Pharm J. 2015. PMID: 25685038 Free PMC article.

2

Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.

Sahin F, Avci CB, Gunduz C, Sezgin C, Simsir IY, Saydam G. Sahin F, et al. Among authors: simsir iy. Hematology. 2010 Jun;15(3):144-50. doi: 10.1179/102453309X12583347113771. Hematology. 2010. PMID: 20557672

3

Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients.

Zengi A, Ercan G, Caglayan O, Tamsel S, Karadeniz M, Simsir I, Harman E, Kahraman C, Orman M, Cetinkalp S, Ozgen G. Zengi A, et al. Exp Clin Endocrinol Diabetes. 2011 Sep;119(8):467-71. doi: 10.1055/s-0031-1275289. Epub 2011 Apr 6. Exp Clin Endocrinol Diabetes. 2011. PMID: 21472659

4

A case of an ectopic prolactinoma.

Simsir IY, Kocabas GU, Sahin SB, Erdogan M, Cetinkalp S, Saygili F, Yilmaz C, Ozgen AG. Simsir IY, et al. Gynecol Endocrinol. 2012 Feb;28(2):148-9. doi: 10.3109/09513590.2011.589923. Epub 2011 Jul 23. Gynecol Endocrinol. 2012. PMID: 21780951

5

Insulin resistance in brain and possible therapeutic approaches.

Cetinkalp S, Simsir IY, Ertek S. Cetinkalp S, et al. Among authors: simsir iy. Curr Vasc Pharmacol. 2014;12(4):553-64. doi: 10.2174/1570161112999140206130426. Curr Vasc Pharmacol. 2014. PMID: 23627981 Review.

6

Development and Optimization of Self-emulsifying Drug Delivery Systems (SEDDS) for Enhanced Dissolution and Permeability of Rosuvastatin.

Karasulu HY, Gündoğdu E, Turgay T, Türk UÖ, Apaydın S, Şimşir IY, Yilmaz C, Karasulu E. Karasulu HY, et al. Among authors: simsir iy. Curr Drug Deliv. 2016;13(3):362-70. doi: 10.2174/156720181303160520211640. Curr Drug Deliv. 2016. PMID: 27230902

7

A novel CYP11B1 mutation in a Turkish patient with 11β-hydroxylase deficiency: An association with the severe hypokalemia leading to rhabdomyolysis.

Yurekli BS, Kutbay NO, Onay H, Simsir IY, Kocabas GU, Erdogan M, Cetinkalp S, Ozgen G, Saygili F. Yurekli BS, et al. Among authors: simsir iy. Hormones (Athens). 2016 Apr;15(2):300-302. doi: 10.14310/horm.2002.1654. Hormones (Athens). 2016. PMID: 27376433 Free article. No abstract available.

8

Risk factors for amputation in patients with diabetic foot infection: a prospective study.

Uysal S, Arda B, Taşbakan MI, Çetinkalp Ş, Şimşir IY, Öztürk AM, Uysal A, Ertam İ. Uysal S, et al. Among authors: simsir iy. Int Wound J. 2017 Dec;14(6):1219-1224. doi: 10.1111/iwj.12788. Epub 2017 Jul 19. Int Wound J. 2017. PMID: 28722354 Free PMC article.

9

Continuation of evolution: Headliner glargine U300.

Soyaltin UE, Şimşir IY, Çetinkalp Ş. Soyaltin UE, et al. Among authors: simsir iy. Med Hypotheses. 2018 Oct;119:24-25. doi: 10.1016/j.mehy.2018.07.019. Epub 2018 Jul 23. Med Hypotheses. 2018. PMID: 30122485 No abstract available.

10

Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers.

Çetinkalp Ş, Gökçe EH, Şimşir I, Tuncay Tanrıverdi S, Doğan F, Biray Avcı Ç, Eroğlu İ, Utku T, Gündüz C, Özer Ö. Çetinkalp Ş, et al. Int J Low Extrem Wounds. 2021 Sep;20(3):217-226. doi: 10.1177/1534734620907773. Epub 2020 Mar 4. Int J Low Extrem Wounds. 2021. PMID: 32131656 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page